Cover Image
市場調查報告書

Menotropins的中國市場分析

Investigation Report on China Menotropins Market, 2010-2019

出版商 China Research and Intelligence 商品編碼 333486
出版日期 內容資訊 英文 30 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
Menotropins的中國市場分析 Investigation Report on China Menotropins Market, 2010-2019
出版日期: 2015年06月18日 內容資訊: 英文 30 Pages
簡介

根據統計資料,中國國內的生產適齡期人口 (20∼29歲的女性人口) 為1億人,其中的12%以上有不孕症煩惱。因為不孕症患者的約30%原因被認為是排卵抑制,排卵抑制的潛在患者可能有360萬人以上。Menotropins在誘導排卵中是最古老的之一,1960年代已經在臨床現場使用。近幾年中國國內Menotropins的需求也急速擴大,2005年達2000萬人民幣的市場規模,以22.8%的年複合成長率(CAGR) 持續增加,2014年達7910萬人民幣。

本報告提供中國的Menotropins的市場相關分析、整體市場規模和國內價格趨勢、各企業、各投藥形態的市場佔有率、主要製造商簡介、今後的市場趨勢預測等調查評估。

第1章 Menotropins的相關概念

  • 症狀
  • 全球市場的銷售情形

第2章 中國的Menotropins市場概況

  • 中國國內的Menotropins專利的申請、認證情形
  • 主要製造商
  • 市場規模

第3章 Menotropins銷售情形分析 (過去5年份)

  • 銷售額
    • 整體銷售額
    • 各地區的銷售額
  • 銷售量
    • 整體銷售量
    • 各地區的銷售量

第4章 中國的Menotropins市場:主要廠商的市場佔有率分析 (過去5年份)

  • 市場佔有率 (銷售額為基礎)
  • 市場佔有率 (銷售量為基礎)

第5章 中國的Menotropins市場:各劑型分析 (過去5年份)

  • 各劑型的市場佔有率 (銷售額為基礎)
  • 各劑型的市場佔有率 (銷售量為基礎)

第6章 Menotropins的醫院用標準價格

  • Shanghai Livzon Pharmaceutical Co., Ltd
  • Livzon Pharmaceutical, Livzon Pharmaceutical Group, Inc
  • Yantai North Pharmaceutical Co., Ltd
  • Ferring Pharmaceytical Co., Ltd (德國)
  • Ma'anshan Fengyuan Pharmaceutical Co., Ltd
  • Ningbo Renjian Pharmaceutical Co., Ltd

第7章 中國國內的Menotropins的主要製造商

  • Livzon Pharmaceutical, Livzon Pharmaceutical Group, Inc
  • Yantai North Pharmaceutical Co., Ltd
  • Ma'anshan Fengyuan Pharmaceutical Co., Ltd
  • Ferring Pharmaceytical Co., Ltd (德國)
  • Shanghai Livzon Pharmaceutical Co., Ltd

第8章 中國的Menotropins市場未來展望 (今後5年份)

  • 市場規模的預測
  • 競爭環境預測

圖表一覽

目錄
Product Code: 1506228

According to the statistics, at present there are about 100 million women in the high-fertility period (aged 20-29) in China, over 12% of whom suffer from infertility. About 30% of female diagnosed with infertility suffer from ovulation inhibition. Herein it can be estimated that the number of potential patients suffering from ovulation inhibition is larger than 3.6 million. Popular clinic drugs utilized in the treatment of ovulation inhibition include clomifene citrate, and gonadotropin (mainly classified into follicle stimulating hormone, menotropins and chorionic gonadotrophin). Gonadotropin is usually utilized if clomifene citrate doesn't work , and sometimes utilized together with clomifene citrate to promote ovulation. chorionic gonadotrophin in combination with follicle stimulating hormone or menotrophins are often applied in the clinic . That is to say,, follicle stimulating hormone or menotrophins is utilized first to foster the growth and maturation of follicle, and then chorionic gonadotrophin is utilized to stimulate ovulation and provide luteal support.

As one of the earliest ovulation stimulants utilized in the clinic , menotropins was utilized in the clinic as early as the 1960s. Extracted from urines of post-menopausal women, menotropins is mainly composed of 75IU ovulation stimulant and 75IU luteinizing hormone. It fosters the growth and maturation of ovulation and affiliates secretion of estrogen within the follicle. In China, there are plenty of manufacturers of menotropins. However, the quality of menotropins produced by these manufacturers is uneven. Menotropins produced by Livzon Pharmaceutical Group Inc, with high purity and outstanding quality, enjoys individual pricing of the development and reform committee, thus its bidding price is slightly higher than that of other manufacturers.

Menotropins has been growing at a rapid pace after entering the Chinese market, with its annual sales value rising from less than CNY 20 million in 2005 to CNY 79.1 million in 2014 and its CAGR from 2005 to 2014 reaching 22.8%. Chinese menotrohins market is mainly dominated by Livzon Pharmaceutical, Livzon Pharmaceutical Group, Inc, Ferring Pharmaceytical Co., Ltd (Germany), Ma'anshan Fengyuan Pharmaceutical Co., Ltd, Yantai North Pharmaceutical Co., Ltd and Shanghai Livzon Pharmaceutical Co., Ltd, among which Shanghai Livzon Pharmaceutical Co., Ltd owns the largest market share, market share for sales value exceeding 60% in 2004.

Readers can have access to the following information through this report:

  • market size of menotropins in China
  • competitive landscape of menotropins in the Chinese market
  • prices of menotropins produced by different enterprises in China
  • market outlook of menotropins in China

The author suggests the following groups of people purchase this report:

  • manufacturers of endocrine and metabolic regulation drugs
  • investors/ research institutions interested in Chinese medicine market
  • any interest in the Chinese medicine market, please contact CRI for customized survey service

Table of Contents

Table of Contents

1. Related Concepts of Menotropins

  • 1.1. Indication
  • 1.2. Sales Status in Global Market

2. Market Profile of Menotropins in China

  • 2.1. Patent and Approval Status of Menotropins in China
  • 2.2. Major Manufacturers
  • 2.3. Market Size

3. Survey on Sales Status of Menotropins in China, 2010-2014

  • 3.1. Sales Value
    • 3.1.1. Overall Sales Value
    • 3.1.2. Sales Value by Regions
  • 3.2. Sales Volume
    • 3.2.1. Overall Sales Volume
    • 3.2.2. Sales Volume by Regions

4. Survey on Market Share of Major Manufacturers of Menotropins in China, 2010-2014

  • 4.1. Market Share by Sales Value
  • 4.2. Market Share by Sales Volume

5. Survey on Dosage Forms of Menotropins in China, 2010-2014

  • 5.1. Share of Different Dosage Forms by Sales Value
  • 5.2. Share of Different Dosage Forms by Sales Volume

6. Reference Price of Menotropins in Chinese Hospitals in 2014

  • 6.1. Shanghai Livzon Pharmaceutical Co., Ltd
  • 6.2. Livzon Pharmaceutical, Livzon Pharmaceutical Group, Inc
  • 6.3. Yantai North Pharmaceutical Co., Ltd
  • 6.4. Ferring Pharmaceytical Co., Ltd (Germany)
  • 6.5. Ma'anshan Fengyuan Pharmaceutical Co., Ltd
  • 6.6. Ningbo Renjian Pharmaceutical Co., Ltd

7. Major Manufacturers of Menotropins in Chinese Market, 2010-2014

  • 7.1. Livzon Pharmaceutical, Livzon Pharmaceutical Group, Inc
  • 7.2. Yantai North Pharmaceutical Co., Ltd
  • 7.3. Ma'anshan Fengyuan Pharmaceutical Co., Ltd
  • 7.4. Ferring Pharmaceytical Co., Ltd (Germany)
  • 7.5. Shanghai Livzon Pharmaceutical Co., Ltd

8. Market Outlook of Menotropins in China, 2015-2019

  • 8.1. Forecast of Market Size
  • 8.2. Forecast of Competitive Landscape

Table of Selected Charts

  • Chart Approval Information of Menotropins in China
  • Chart Sales Status of Menotropins in Chinese Market, 2010-2014
  • Chart Sales Value of Menotropins in China, 2010-2014
  • Chart Sales Value of Menotropins in Some Regions of China, 2010-2014
  • Chart Sales Volume of Menotropins in China, 2010-2014
  • Chart Market Share of TOP5 Manufacturers of Menotropins for Sales Value in China, 2010-2014
  • Chart Sales Value and Market Share of Menotropins Produced by Livzon Pharmaceutical Co., Ltd in China, 2010-2014
  • Chart Sales Value and Market Share of Menotropins Produced by Ferring Pharmaceutical Co., Ltd (Germany) in China, 2010-2014
  • Chart Sales Value and Market Share of Menotropins Produced by Shanghai Livzon Pharmaceutical Co., Ltd in China, 2010-2014
  • Chart Sales Value and Market Share of Menotropins Produced by Yantai North Pharmaceutical Co., Ltd in China, 2010-2014
  • Chart Sales Value and Market Share of Menotropins Produced by Ma'anshan Fengyuan Pharmaceutical Co., Ltd in China, 2010-2014
  • Chart Price of Menotropins Produced by Shanghai Livzon Pharmaceutical Co., Ltd in Some Cities of China in 2014
  • Chart Price of Menotropins Produced by Livzon Pharmaceutical, Livzon Pharmaceutical Group Inc in Some Cities of China in 2014
  • Chart Price of Menotropins Produced by Yantai North Pharmaceutical Co., Ltd in Some Cities of China in 2014
  • Chart Price of Menotropins Produced by Ferring Pharmaceutical Co., Ltd in Some Cities of China in 2014
  • Chart Price of Menotropins Produced by Ma'anshan Fengyuan Pharmaceutical Co., Ltd in Some Cities of China in 2014
  • Chart Price of Menotropins Produced by Ningbo Renjian Pharmaceutical Co., Ltd in Some Cities of China in 2014
Back to Top